11 – 20 of 33
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
(
- Contribution to journal › Article
- 2015
-
Mark
A template for writing radiotherapy protocols.
(
- Contribution to journal › Article
-
Mark
The water-perfusable tissue fraction of colorectal cancer metastases is increased by the selective PDGF-receptor inhibitor imatinib but not the IL-1 receptor antagonist anakinra, a study using serial dynamic 15O-water PET.
(
- Contribution to journal › Article
- 2014
-
Mark
Acta Oncologica and a new generation of scientists in oncology
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines.
(
- Contribution to journal › Article
-
Mark
Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region.
(
- Contribution to journal › Article
- 2013
-
Mark
Validation of the Distress Thermometer in a Swedish population of oncology patients; accuracy of changes during six months
(
- Contribution to journal › Article
-
Mark
Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy
(
- Contribution to journal › Article
- 2012
-
Mark
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study.
(
- Contribution to journal › Article
- 2011
-
Mark
Particle Therapy - A next logical step in the improvement of radiotherapy
(
- Contribution to journal › Debate/Note/Editorial